#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17152	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2060	826.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1385	1385	C	1049	C,T	979,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31394	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3654	856.8	0	.	n	.	0	T695C	SNP	695	695	T	1049	1049	C	1027	C,T	939,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31394	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3654	856.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1691	1691	A	1092	A,G	1013,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31394	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3654	856.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2325	2325	C	970	C,T	903,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31394	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3654	856.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2951	2951	T	950	T,C	666,231	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31394	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3654	856.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2399	2399	A	978	A	935	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2434	folP	852	852	100.0	folP.l15.c17.ctg.1	1500	161.4	1	SNP	p	R228S	1	.	.	682	684	AGC	983	985	AGC	247;250;255	A;G;C,T	226;229;231,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6232	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3383	183.6	1	SNP	p	S91F	0	.	.	271	273	TCC	544	546	TCC	213;214;218	T;C;C	202;202;207	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6232	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3383	183.6	1	SNP	p	D95G	0	.	.	283	285	GAC	556	558	GAC	219;220;216	G;A;C	205;207;204	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6232	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3383	183.6	1	SNP	p	D95N	0	.	.	283	285	GAC	556	558	GAC	219;220;216	G;A;C	205;207;204	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1876	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1310	142.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	395	397	ACC	217;216;214	A,G;C;C	203,1;207;205	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1876	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1310	142.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	410	412	CAC	215;218;222	C;A,G;C	200;201,1;211	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1876	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1310	142.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	593	595	CAC	251;249;251	C;A;C	233;228;235	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1876	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1310	142.3	1	SNP	p	G45D	0	.	.	133	135	GGC	413	415	GGC	223;227;227	G;G;C	210;210;213	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1032	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	967	105.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6184	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	199.0	1	SNP	p	D86N	0	.	.	256	258	GAC	710	712	GAC	295;296;296	G,A;A;C	261,1;261;264	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6184	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	199.0	1	SNP	p	S87R	0	.	.	259	261	AGT	713	715	AGT	296;294;290	A;G;T	261;265;261	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6184	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	199.0	1	SNP	p	S87I	0	.	.	259	261	AGT	713	715	AGT	296;294;290	A;G;T	261;265;261	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6184	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	199.0	1	SNP	p	S87W	0	.	.	259	261	AGT	713	715	AGT	296;294;290	A;G;T	261;265;261	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6184	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	199.0	1	SNP	p	S88P	0	.	.	262	264	TCC	716	718	TCC	291;294;295	T;C;C	264;269;269	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5164	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2592	198.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1509	1511	GGC	269;265;265	G;G;C	252;247;245	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1232	1234	GCA	233;238;237	G;C;A	214;220;221	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1235	1237	ATC	238;239;239	A;T;C	221;223;223	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1247	1249	GTG	236;237;242	G;T;G	217;216;221	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1247	1249	GTG	236;237;242	G;T;G	217;216;221	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1751	1753	ACC	243;245;249	A,C;C;C	223,1;225;232	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1805	1807	GCG	246;248;246	G;C;G	228;205;216	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1805	1807	GCG	246;248;246	G;C;G	228;205;216	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1928	1930	GGC	205;205;200	G;G;C	186;187;182	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1937	1939	GGC	194;195;196	G;G;C	173;177;177	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4722	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2325	201.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1955	1957	CCG	167;166;162	C,CGGG;C,G;G	124,1;124,1;121	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6628	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3253	203.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2716	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1689	159.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	179	C	158	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	452	454	GGA	272;270;274	G;G;A	254;254;257	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	0	.	p	.	0	F135L	NONSYN	403	405	TTT	713	715	CTT	259;262;259	C;T;T	245;248;244	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	737	739	GGA	262;261;258	G;G;A,G	241;240;234,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	0	.	p	.	0	D171G	NONSYN	511	513	GAT	821	823	GGT	242;242;244	G;G;T	223;227;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	0	.	p	.	0	G189S	NONSYN	565	567	GGC	875	877	AGC	225;222;221	A,G;G;C	207,1;207;206	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	941	941	T	216	T	205	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	1	SNP	p	G120K	0	.	.	358	360	GGT	668	670	GGT	249;249;248	G;G;T	229;231;221	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	1	SNP	p	A121D	0	.	.	361	363	GCC	671	673	GCC	248;248;248	G;C;C	227;230;232	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3138	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1505	207.1	1	SNP	p	A121N	0	.	.	361	363	GCC	671	673	GCC	248;248;248	G;C;C	227;230;232	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12182	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4831	251.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2017	2019	AAT	271;274;275	A;A;T	257;262;259	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1248	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	929	133.6	1	SNP	p	V57M	1	.	.	169	171	ATG	474	476	ATG	281;280;278	A;T;G	261;260;257	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
